{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:34Z","timestamp":1791908674400,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["CPRIT RP200443"],"award-info":[{"award-number":["CPRIT RP200443"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["P30 CA08748"],"award-info":[{"award-number":["P30 CA08748"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180672"],"award-info":[{"award-number":["RP180672"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA269733"],"award-info":[{"award-number":["R01CA269733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2CA225212"],"award-info":[{"award-number":["DP2CA225212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA125123"],"award-info":[{"award-number":["P30CA125123"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Marie-Jos\u00e9e and Henry R. Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["R21AI159379"],"award-info":[{"award-number":["R21AI159379"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["CA210522"],"award-info":[{"award-number":["CA210522"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","award":["DP2CA225212"],"award-info":[{"award-number":["DP2CA225212"]}],"id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","award":["R01CA269733"],"award-info":[{"award-number":["R01CA269733"]}],"id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018897","name":"Lions Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["S10RR024574"],"award-info":[{"award-number":["S10RR024574"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ccell.2024.05.025","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:48:23Z","timestamp":1718880503000},"page":"1202-1216.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors"],"prefix":"10.1016","volume":"42","author":[{"given":"Gabriel","family":"Espinosa-Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Scrivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Betel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-1687","authenticated-orcid":false,"given":"Andrea","family":"Schietinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2024.05.025_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-021-00574-3","article-title":"CD8(+) T\u00a0cell differentiation and dysfunction in cancer","volume":"22","author":"Philip","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles Posed by the Tumor Microenvironment to T\u00a0cell Activity: A Case for Synergistic Therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.025_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/bs.ai.2015.12.006","article-title":"Adoptive T-Cell Therapy for Cancer","volume":"130","author":"Yang","year":"2016","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.025_bib6","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/1078-0432.CCR-15-0860","article-title":"New Strategies in Engineering T-cell Receptor Gene-Modified T\u00a0cells to More Effectively Target Malignancies","volume":"21","author":"Schmitt","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction","volume":"323","author":"Rosenberg","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1089\/hum.2009.146","article-title":"T cell receptor gene therapy for cancer","volume":"20","author":"Schmitt","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ccell.2024.05.025_bib9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.025_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/PPO.0b013e3181eb3879","article-title":"Adoptive cell therapy: genetic modification to redirect effector cell specificity","volume":"16","author":"Morgan","year":"2010","journal-title":"Cancer J."},{"key":"10.1016\/j.ccell.2024.05.025_bib11","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.0405730101","article-title":"Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes","volume":"101","author":"Rosenberg","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.025_bib12","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib13","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T\u00a0cell therapy using antigen-specific CD8+ T\u00a0cell clones for the treatment of patients with metastatic melanoma: in\u00a0vivo persistence, migration, and antitumor effect of transferred T\u00a0cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.025_bib14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","article-title":"T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant","volume":"25","author":"Chapuis","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.025_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ccell.2015.09.022","article-title":"T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma","volume":"28","author":"Stromnes","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.025_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.immunol.25.022106.141527","article-title":"Improving T\u00a0cell therapy for cancer","volume":"25","author":"Leen","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181b88ffc","article-title":"Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T\u00a0cells","volume":"33","author":"Wrzesinski","year":"2010","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ccell.2024.05.025_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.it.2004.12.003","article-title":"Sinks, suppressors and antigen presenters: how lymphodepletion enhances T\u00a0cell-mediated tumor immunotherapy","volume":"26","author":"Klebanoff","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib20","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1073\/pnas.0307298101","article-title":"IL-15 enhances the in\u00a0vivo antitumor activity of tumor-reactive CD8+ T\u00a0cells","volume":"101","author":"Klebanoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.025_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T\u00a0cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib22","doi-asserted-by":"crossref","first-page":"eadf3700","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-engineered T\u00a0cell therapy in solid tumors: State of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ccell.2024.05.025_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/imr.12772","article-title":"T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance","volume":"290","author":"Chandran","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ccell.2024.05.025_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4(+) T\u00a0cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib25","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib28","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T\u00a0cells to sites of CD4+ T\u00a0cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.23.021704.115825","article-title":"Cooperation between CD4+ and CD8+ T\u00a0cells: when, where, and how","volume":"24","author":"Castellino","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib30","doi-asserted-by":"crossref","first-page":"19414","DOI":"10.1073\/pnas.0807743105","article-title":"Memory-like CD8+ and CD4+ T\u00a0cells cooperate to break peripheral tolerance under lymphopenic conditions","volume":"105","author":"Le Saout","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.025_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib32","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1158\/0008-5472.CAN-10-1322","article-title":"CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes","volume":"70","author":"Bos","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1084\/jem.161.5.1122","article-title":"Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T\u00a0cells. Tumor eradication does not require participation of cytotoxic T\u00a0cells","volume":"161","author":"Greenberg","year":"1985","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib34","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.4049\/jimmunol.154.9.4613","article-title":"Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T\u00a0cells that are cytolytic in\u00a0vitro and tumoricidal in\u00a0vivo","volume":"154","author":"Frey","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib35","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1073\/pnas.96.15.8633","article-title":"CD4(+) T\u00a0cells eliminate MHC class II-negative cancer cells in\u00a0vivo by indirect effects of IFN-gamma","volume":"96","author":"Mumberg","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.025_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/1074-7613(95)90078-0","article-title":"A unique tumor antigen produced by a single amino acid substitution","volume":"2","author":"Monach","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.05.025_bib37","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/blood-2006-10-051318","article-title":"CD4 cells can be more efficient at tumor rejection than CD8 cells","volume":"109","author":"Perez-Diez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.025_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(00)80218-6","article-title":"CD4+ T\u00a0cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells","volume":"12","author":"Qin","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.05.025_bib39","first-page":"2611","article-title":"Human CD4+ effector T\u00a0cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice","volume":"62","author":"Egilmez","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib40","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4049\/jimmunol.174.2.898","article-title":"Human CD4+ effector memory T\u00a0cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells","volume":"174","author":"Broderick","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2024.05.025_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-2776(08)60778-6","article-title":"Adoptive T\u00a0cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells","volume":"49","author":"Greenberg","year":"1991","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib43","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T\u00a0cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11824","article-title":"T-helper-1-cell cytokines drive cancer into senescence","volume":"494","author":"Braumuller","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ccr.2008.04.001","article-title":"TNFR1 signaling and IFN-gamma signaling determine whether T\u00a0cells induce tumor dormancy or promote multistage carcinogenesis","volume":"13","author":"Muller-Hermelink","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2024.05.025_bib46","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1084\/jem.20092450","article-title":"Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T\u00a0cells during the effector phase","volume":"207","author":"Schietinger","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib47","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3389\/fimmu.2017.02001","article-title":"CD4(+) T Helper Cells Play a Key Role in Maintaining Diabetogenic CD8(+) T Cell Function in the Pancreas","volume":"8","author":"Espinosa-Carrasco","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.1251102","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T\u00a0cells in a patient with epithelial cancer","volume":"344","author":"Tran","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.025_bib52","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of metastatic melanoma with autologous CD4+ T\u00a0cells against NY-ESO-1","volume":"358","author":"Hunder","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1084\/jem.154.3.952","article-title":"Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes","volume":"154","author":"Greenberg","year":"1981","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib54","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1084\/jem.20050732","article-title":"Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T\u00a0cells","volume":"202","author":"Gattinoni","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1324-y","article-title":"TOX is a critical regulator of tumour-specific T\u00a0cell differentiation","volume":"571","author":"Scott","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib56","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13073-020-00722-9","article-title":"Single-cell transcriptome analysis reveals TOX as a promoting factor for T\u00a0cell exhaustion and a predictor for anti-PD-1 responses in human cancer","volume":"12","author":"Kim","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib57","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1073\/pnas.1905675116","article-title":"TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8(+) T\u00a0cell exhaustion","volume":"116","author":"Seo","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2024.05.025_bib58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jhep.2019.05.015","article-title":"TOX promotes the exhaustion of antitumor CD8(+) T\u00a0cells by preventing PD1 degradation in hepatocellular carcinoma","volume":"71","author":"Wang","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ccell.2024.05.025_bib59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T\u00a0cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T\u00a0cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2024.05.025_bib61","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.4049\/jimmunol.167.9.4791","article-title":"Cutting edge: CCR4 mediates antigen-primed T\u00a0cell binding to activated dendritic cells","volume":"167","author":"Wu","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib62","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.abb9847","article-title":"Stem-like CD8 T\u00a0cells mediate response of adoptive cell immunotherapy against human cancer","volume":"370","author":"Krishna","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ccell.2024.05.025_bib63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1074-7613(02)00365-5","article-title":"In\u00a0vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T\u00a0cells by exogenous cell-associated antigens","volume":"17","author":"Jung","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2024.05.025_bib64","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/eji.1830171109","article-title":"Three-cell-type clusters of T\u00a0cells with antigen-presenting cells best explain the epitope linkage and noncognate requirements of the in\u00a0vivo cytolytic response","volume":"17","author":"Mitchison","year":"1987","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory Pathways in Immunotherapy for Cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib66","doi-asserted-by":"crossref","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ccell.2024.05.025_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/EDBK_240837","article-title":"Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?","volume":"39","author":"Fares","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.ccell.2024.05.025_bib69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1078-0432.CCR-22-2566","article-title":"A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1084\/jem.155.3.768","article-title":"Helper activity is required for the in\u00a0vivo generation of cytotoxic T lymphocytes","volume":"155","author":"Keene","year":"1982","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib71","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.4049\/jimmunol.165.8.4246","article-title":"Divergent roles for CD4+ T\u00a0cells in the priming and effector\/memory phases of adoptive immunotherapy","volume":"165","author":"Hu","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib72","first-page":"6438","article-title":"Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T\u00a0cell to a fully functional tumor killer cell","volume":"62","author":"Gao","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib73","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.152.2.549","article-title":"Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in\u00a0vivo with peptide vaccine constructs","volume":"152","author":"Shirai","year":"1994","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ccell.2024.05.025_bib74","doi-asserted-by":"crossref","first-page":"e164258","DOI":"10.1172\/JCI164258","article-title":"Linked CD4+\/CD8+ T\u00a0cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression","volume":"133","author":"Dolina","year":"2023","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccell.2024.05.025_bib75","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrc2373","article-title":"Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines","volume":"8","author":"Melief","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2024.05.025_bib76","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T\u00a0cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib77","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26677","article-title":"Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer","volume":"2","author":"Schietinger","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ccell.2024.05.025_bib78","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201966","article-title":"TCR signal strength defines distinct mechanisms of T\u00a0cell dysfunction and cancer evasion","volume":"219","author":"Shakiba","year":"2022","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ccell.2024.05.025_bib79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.025_bib80","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.025_bib81","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2024.05.025_bib82","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ccell.2024.05.025_bib83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.ccell.2024.05.025_bib84","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.025_bib85","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.ccell.2024.05.025_bib86","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2024.05.025_bib87","series-title":"DiffBind: differential binding analysis of ChIP-Seq peak data","author":"Stark","year":"2011"},{"key":"10.1016\/j.ccell.2024.05.025_bib88","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1002\/cpz1.585","article-title":"Exploring Epigenomic Datasets by ChIPseeker","volume":"2","author":"Wang","year":"2022","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.ccell.2024.05.025_bib89","doi-asserted-by":"crossref","first-page":"W187","DOI":"10.1093\/nar\/gku365","article-title":"deepTools: a flexible platform for exploring deep-sequencing data","volume":"42","author":"Ramirez","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2024.05.025_bib90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/bib\/bbs038","article-title":"The UCSC genome browser and associated tools","volume":"14","author":"Kuhn","year":"2013","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ccell.2024.05.025_bib91","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2024.05.025_bib92","series-title":"profileplyr: Visualization and annotation of read signal over genomic ranges with profileplyr (R package)","author":"Carroll","year":"2023"},{"key":"10.1016\/j.ccell.2024.05.025_bib93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2024.05.025_bib94","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.ccell.2024.05.025_bib95","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","article-title":"ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.025_bib96","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2024.05.025_bib97","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik:\u00a0interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2024.05.025_bib98","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41587-021-01094-0","article-title":"Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning","volume":"40","author":"Greenwald","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2024.05.025_bib99","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ccell.2024.05.025_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610824001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:23:50Z","timestamp":1778617430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610824001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":100,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1535610824001934"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2024.05.025","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2024.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}